» Articles » PMID: 16177006

Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized Patients

Overview
Specialty Nephrology
Date 2005 Sep 24
PMID 16177006
Citations 1321
Authors
Affiliations
Soon will be listed here.
Abstract

The marginal effects of acute kidney injury on in-hospital mortality, length of stay (LOS), and costs have not been well described. A consecutive sample of 19,982 adults who were admitted to an urban academic medical center, including 9210 who had two or more serum creatinine (SCr) determinations, was evaluated. The presence and degree of acute kidney injury were assessed using absolute and relative increases from baseline to peak SCr concentration during hospitalization. Large increases in SCr concentration were relatively rare (e.g., >or=2.0 mg/dl in 105 [1%] patients), whereas more modest increases in SCr were common (e.g., >or=0.5 mg/dl in 1237 [13%] patients). Modest changes in SCr were significantly associated with mortality, LOS, and costs, even after adjustment for age, gender, admission International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis, severity of illness (diagnosis-related group weight), and chronic kidney disease. For example, an increase in SCr >or=0.5 mg/dl was associated with a 6.5-fold (95% confidence interval 5.0 to 8.5) increase in the odds of death, a 3.5-d increase in LOS, and nearly 7500 dollars in excess hospital costs. Acute kidney injury is associated with significantly increased mortality, LOS, and costs across a broad spectrum of conditions. Moreover, outcomes are related directly to the severity of acute kidney injury, whether characterized by nominal or percentage changes in serum creatinine.

Citing Articles

Nephroprotective and Antioxidant Effects of Extract Against Ischemia-Reperfusion Injury in Wistar Rats.

Rodriguez-Rodriguez D, Mendoza-Hernandez O, Cordero-Perez P, Rivas-Galindo V, Moreno-Pena D, Tijerina-Marquez R Int J Mol Sci. 2025; 26(5).

PMID: 40076464 PMC: 11899379. DOI: 10.3390/ijms26051838.


Unveiling the therapeutic potential of berberine: its therapeutic role and molecular mechanisms in kidney diseases.

Fan Z, Wei X, Zhu X, Yang K, Tian L, Wang X Front Pharmacol. 2025; 16:1549462.

PMID: 40061955 PMC: 11885249. DOI: 10.3389/fphar.2025.1549462.


Unexpectedly high rate of unrecognized acute kidney injury and its trend over the past 14 years.

Han L, Li H, Luo L, Ye X, Ren Y, Xu Z Sci Rep. 2025; 15(1):6305.

PMID: 39984512 PMC: 11845613. DOI: 10.1038/s41598-025-88732-8.


Ten tips on how to reduce iatrogenic acute kidney injury.

Booke H, von Groote T, Zarbock A Clin Kidney J. 2025; 18(2):sfae412.

PMID: 39950155 PMC: 11822294. DOI: 10.1093/ckj/sfae412.


Epidemiological risk factors for acute kidney injury outcomes in hospitalized adult patients: a multicenter cohort study.

Takeuchi T, Rahman A, Ghazi L, Moe O, Toto R, Siew E Clin Kidney J. 2025; 18(2):sfae426.

PMID: 39935738 PMC: 11811520. DOI: 10.1093/ckj/sfae426.